Exogenous FABP4 induces endoplasmic reticulum stress in HepG2 liver cells

Atherosclerosis

Volumn 249, Issue , 2016, Pages 191-199

  Bosquet, Alba ^a   Guaita Esteruelas, Sandra ^a   Saavedra, Paula ^a   Rodríguez Calvo, Ricardo ^a   Heras, Mercedes ^a   Girona, Josefa ^a   Masana, Lluís ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

Author keywords

Apoptosis; Fatty acid; Fatty acid binding protein; Fatty acid transport; Hepatocytes; Linoleate; Signal transduction

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN 4; FLUORESCEIN ISOTHIOCYANATE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INITIATION FACTOR 2ALPHA; LINOLEIC ACID; LIPOCORTIN 5; PROTEIN IRE1; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN; ERN1 PROTEIN, HUMAN; FABP4 PROTEIN, HUMAN; FATTY ACID; FATTY ACID BINDING PROTEIN; INSULIN; LIPID; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN SERINE THREONINE KINASE; RIBONUCLEASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; OBESITY; PRIORITY JOURNAL; PROPIDIUM IODIDE ASSAY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UBIQUITINATION; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; GENETICS; HEP-G2 CELL LINE; LIVER; LIVER CELL; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; ENDORIBONUCLEASES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HEP G2 CELLS; HEPATOCYTES; HUMANS; INSULIN; LIPIDS; LIVER; MAP KINASE KINASE 4; OBESITY; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84966389254     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.04.012     Document Type: Article

References (36)

1. Xu H., Hertzel A.V., Steen K.A., Wang Q., Suttles J., Bernlohr D.A. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2. Mol. Cell. Biol. 2015, 35:1055-1065. 10.1128/MCB.01122-14.
2. Ozcan U., Cao Q., Yilmaz E., Lee A.-H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461. 10.1126/science.1103160.
3. Flamment M., Hajduch E., Ferré P., Foufelle F. New insights into ER stress-induced insulin resistance. Trends Endocrinol. Metab. 2012, 23:381-390. 10.1016/j.tem.2012.06.003.
4. Boden G. Obesity and free fatty acids. Endocrinol. Metab. Clin. N. Am. 2008, 37:635-646. viii-ix. 10.1016/j.ecl.2008.06.007.
5. Delarue J., Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:142-148. 10.1097/MCO.0b013e328042ba90.
6. Zhang Y., Xue R., Zhang Z., Yang X., Shi H. Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. Lipids Health Dis. 2012, 11:1. 10.1186/1476-511X-11-1.
7. Lu J., Wang Q., Huang L., Dong H., Lin L., Lin N., et al. Palmitate causes endoplasmic reticulum stress and apoptosis in human mesenchymal stem cells: prevention by AMPK activator. Endocrinology 2012, 153:5275-5284. 10.1210/en.2012-1418.
8. Wei Y., Wang D., Topczewski F., Pagliassotti M.J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E275-E281. 10.1152/ajpendo.00644.2005.
9. Cui W., Ma J., Wang X., Yang W., Zhang J., Ji Q. Free fatty acid induces endoplasmic reticulum stress and apoptosis of β-cells by Ca2+/calpain-2 pathways. PLoS One 2013, 8:e59921. 10.1371/journal.pone.0059921.
10. Hetz C., Chevet E., Harding H.P. Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 2013, 12:703-719. 10.1038/nrd3976.
11. Erbay E., Babaev V.R., Mayers J.R., Makowski L., Charles K.N., Snitow M.E., et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med. 2009, 15:1383-1391. 10.1038/nm.2067.
12. Malhi H., Kaufman R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 2011, 54:795-809. 10.1016/j.jhep.2010.11.005.
13. Furuhashi M., Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 2008, 7:489-503. 10.1038/nrd2589.
14. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., Zhang J., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem. 2006, 52:405-413. 10.1373/clinchem.2005.062463.
15. Cabré A., Lázaro I., Cofán M., Jarauta E., Plana N., Garcia-Otín A.L., et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J. Lipid Res. 2010, 51:1173-1178. 10.1194/jlr.M900066.
16. Cabré A., Lázaro I., Girona J., Manzanares J.M., Marimón F., Plana N., et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007, 195:e150-e158. 10.1016/j.atherosclerosis.2007.04.045.
17. Cabré A., Lázaro I., Girona J., Manzanares J.M., Marimón F., Plana N., et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res. 2008, 49:1746-1751. 10.1194/jlr.M800102-JLR200.
18. Kralisch S., Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?. Diabetologia 2013, 56:10-21. 10.1007/s00125-012-2737-4.
19. Aragonès G., Saavedra P., Heras M., Cabré A., Girona J., Masana L. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc. Diabetol. 2012, 11:72. 10.1186/1475-2840-11-72.
20. Saavedra P., Girona J., Aragonès G., Cabré A., Guaita S., Heras M., et al. Interaction of FABP4 with plasma membrane proteins of endothelial cells. Clin. Investig. Arterioscler. 2015, 27:26-33. 10.1016/j.arteri.2014.05.003.
21. Girona J., Rosales R., Plana N., Saavedra P., Masana L., Vallvé J.-C. FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS One 2013, 8:e81914. 10.1371/journal.pone.0081914.
22. Yao F., Li Z., Ehara T., Yang L., Wang D., Feng L., et al. Fatty acid-binding protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy. Mol. Cell. Endocrinol. 2015, 10.1016/j.mce.2015.05.003.
23. Kajimoto K., Minami Y., Harashima H. Cytoprotective role of the fatty acid binding protein 4 against oxidative and endoplasmic reticulum stress in 3T3-L1 adipocytes. FEBS Open Bio 2014, 4:602-610. 10.1016/j.fob.2014.06.008.
24. Cabré A., Lázaro I., Girona J., Manzanares J.M., Marimón F., Plana N., et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res. 2008, 49:1746-1751. 10.1194/jlr.M800102-JLR200.
25. Greenspan P., Mayer E.P., Fowler S.D. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 1985, 100:965-973. (accessed 10.03.16). http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2113505&tool=pmcentrez&rendertype=abstract.
26. Schröder M., Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 2005, 74:739-789. 10.1146/annurev.biochem.73.011303.074134.
27. Schröder M., Kaufman R.J. ER stress and the unfolded protein response. Mutat. Res. 2005, 569:29-63. 10.1016/j.mrfmmm.2004.06.056.
28. Fu S., Watkins S.M., Hotamisligil G.S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012, 15:623-634. 10.1016/j.cmet.2012.03.007.
29. Leamy A.K., Egnatchik R.A., Shiota M., Ivanova P.T., Myers D.S., Brown H.A., et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 2014, 55:1478-1488. 10.1194/jlr.M050237.
30. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846. 10.1038/nature05482.
31. Gu X., Li K., Laybutt D.R., He M., Zhao H.-L., Chan J.C.N., et al. Bip overexpression, but not CHOP inhibition, attenuates fatty-acid-induced endoplasmic reticulum stress and apoptosis in HepG2 liver cells. Life Sci. 2010, 87:724-732. 10.1016/j.lfs.2010.10.012.
32. Urra H., Dufey E., Lisbona F., Rojas-Rivera D., Hetz C. When ER stress reaches a dead end. Biochim. Biophys. Acta 2013, 1833:3507-3517. 10.1016/j.bbamcr.2013.07.024.
33. Furuhashi M., Tuncman G., Görgün C.Z., Makowski L., Atsumi G., Vaillancourt E., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447:959-965. 10.1038/nature05844.
34. Hoo R.L.C., Lee I.P.C., Zhou M., Wong J.Y.L., Hui X., Xu A., et al. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J. Hepatol. 2013, 58:358-364. 10.1016/j.jhep.2012.10.022.
35. Atshaves B.P., Martin G.G., Hostetler H.A., McIntosh A.L., Kier A.B., Schroeder F. Liver fatty acid-binding protein and obesity. J. Nutr. Biochem. 2010, 21:1015-1032. 10.1016/j.jnutbio.2010.01.005.
36. Lamounier-Zepter V., Look C., Alvarez J., Christ T., Ravens U., Schunck W.-H., et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ. Res. 2009, 105:326-334. 10.1161/CIRCRESAHA.109.200501.